太美医疗科技2025年中期报告

浙江太美醫療科技股份有限公司Zhejiang Taimei Medical Technology Co., Ltd. （於中華人民共和國註冊成立的股份有限公司）Stock Code 股份代號 : 2576(A joint stock company incorporated in the People’s Republic of China with limited liability) 249102132333435373839 22 3693 18819 20253242025324 H 183171712-1716 82404001 1818 2576 10291 www.taimei.com 131 77334 2016117 2024630272.810.5%2025630244.2 2024630110.99.7%2025630100.2202463040.7%202563041.0% 202563029.32024630175.328.741.7% SaaSSaaSTrialsPharmaOSAITrialsPharmaOS TrialsPharmaOSCRO/SMOTrialsPharmaOS TrialsPharmaOSSaaSSaaSTrialsPharmaOS SaaS 202538.7%SaaS SMOSaaS IRCSMOSMO 202561.2% •AI 2025AISaaSAIaaSAI as a serviceAI ✓iDMCRF80%50% ✓i C T AA I70%✓iPV(ICSR)300%✓iSeeKAI716✓iMAP AI AIaaS A I a a SiDMiCTA iPVTrials/PharmaOS+ IT 201015AIHIPAAPDPAICH-GCPAI (i)SaaS(ii)IRC 2024630272.810.5%2025630244.2 202463097.63.0%202563094.6202463016.0202563012.2 2024630175.214.8%2025630149.4 2024630161.811.0%2025630144.0 2024630110.99.7%2025630100.2202463040.7%202563041.0% 202463051.226.6%202563037.68.63.1 2024630217.273.4%202563057.7(i)121.320241(ii)30.3 202463050.926.0%202563037.710.2 202463020256301.35.5 20246309.820256302.46.8 202563012.916.120246307.85.3 202463016.7202563019.42.8 2024630175.383.3%202563029.3 2025630 2025630 20256301,170.8202412311,184.5253.0736.1160.10.120241231319.3599.9159.45.12024123110.0 2025630(1)5.66202412315.05(2)19.9%2024123122.0% (1)(2)100% 2025630 2025630202563010.520246302.116.120246305.3 2025630 2025630 2025630 2025630 2025630656648442025630 2025630152.12024630209.6 H2024108259.5 2025630 2024630 C12 F.1.110%50%(i)(ii) C3 20256302025630 3.10(2) 2025630 202572520257252025725 2025630XVXV78352 2025630563,779,000363,186,467200,592,533H 2.202563093,042,38874.94%85,160,6401,216,500H 3.202563039.42%20,312,190 2025630XVXV78352 2025630XV23336 2025630563,779,000363,186,467200,592,533H 2.93,042,388202563074.94%85,160,6401,216,500H 202563095%99%23,585,382H 3.70080700 4. 80% 80% 22,349,53328,100,879H23,908,95330,061,593H 6.50%25%25%15,930,44915,930,449H 80% 10,889,262H 8.8340891,609,427H 8,484,798H 9.8,505,66510,694,479H 95% 90% 60% 9,770,76612,285,138H 11. 2025630XV23336 202413.51B(1) 13.2013.2113.22 2025828 337020256303434 2410 34 2025828 2025630 33702025828 2025630 1 2013662020911 2024108 2025828 2 20256303420241231 2025630 3 20241231 (a) 202511 (b) 202511 7979 19181028 2025630 4 (a) 202563020241231 2025630 4 (a) 11 22 33 (b) • • 4 (c)3 20256303 2025630 4 (c)3 (i) 3 2025630 1%2025630344,0002024630342,000 5 SaaS 202563010% (a) 2025630 (b) 2025630 2025630 6 2025630 6 (a) (b) 2025630 7 8 (a) 9 2025630 11 (i) 25% 202563015% 202563020%202463020% 2025630 11 (ii) 17%2025630202463017% (iii) 21%1%12%2025630202463021%1%12% 12 2025630 202563020256302024630 2025630 13 6302024630 14 2025630 15 (a) 2025630 15 (b) 20256307,075,000202463013,044,000 15 (c) 2025630 16 2025630 16 2025630 (a) 201962820191129139,646,00021,480,000 17 2025630 17 26 19 2025630 19 (a)180 (b) 30120 2025630 21 151 23 (a) 2025630100,00020241231100,0005,000,000 202312315,000,0002025630 (b)2025630 2025630 24 26 (a)2022123121.49%50,000,000330,140,00020,000,00080%20266301 28,796,00020256309 2025630 27 2016 (a) 2025630 27 (b) 2025630 2025630 27 (c)2025630 2025630 28 28 2025630 29 2025630 30 (a) 2025630 (i) 20256302,190,00020246301,919,000 31 202563028(b) (b)2025630 32 2025630